{"id":"NCT01346592","sponsor":"Novartis Vaccines","briefTitle":"Safety, Tolerability, and Immunogenicity of the Adjuvanted Trivalent Subunit Influenza Vaccine and the Non-Adjuvanted Trivalent Subunit Influenza Vaccine Compared to the Non-Adjuvanted Trivalent Split Influenza Vaccine in Children 6 to < 72 Months of Age","officialTitle":"A Phase III, Observer-Blind, Randomized, Multi-center Study to Evaluate the Safety, Tolerability, and Immunogenicity of Fluad and Agriflu Compared to the Non-adjuvanted Trivalent Influenza Vaccine Fluzone in Children 6 to < 72 Months of Age","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-04","primaryCompletion":"2012-07","completion":"2012-07","firstPosted":"2011-05-03","resultsPosted":"2014-05-06","lastUpdate":"2015-03-26"},"enrollment":6104,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"SINGLE","primaryPurpose":"PREVENTION"},"conditions":["Influenza Disease"],"interventions":[{"type":"BIOLOGICAL","name":"Trivalent split influenza vaccine (TIV)","otherNames":["Agriflu"]},{"type":"BIOLOGICAL","name":"MF59-adjuvanted trivalent influenza vaccine (aTIV)","otherNames":["Fluad"]},{"type":"BIOLOGICAL","name":"Licensed comparator trivalent split influenza vaccine (comparator TIV)","otherNames":["Fluzone"]}],"arms":[{"label":"aTIV (6 to <72 months)","type":"ACTIVE_COMPARATOR"},{"label":"Comparator TIV (6 to <72 months)","type":"ACTIVE_COMPARATOR"},{"label":"TIV (6 to <72 months)","type":"ACTIVE_COMPARATOR"}],"summary":"This Study Aims to Evaluate the Safety, Tolerability, and Immunogenicity of the Adjuvanted Trivalent Subunit Influenza Vaccine and the Non-Adjuvanted Trivalent Subunit Influenza Vaccine Compared to the Non-Adjuvanted Trivalent Split Influenza Vaccine in Children 6 to \\< 72 Months of Age.","primaryOutcome":{"measure":"Comparison of Antibody Responses of aTIV With TIV and Comparator TIV in Terms of Geometric Mean Titers (GMTs) Against Homologous Strains","timeFrame":"Day 1, Day 50","effectByArm":[{"arm":"aTIV (6 to <72 Months)","deltaMin":28,"sd":null},{"arm":"Comparator TIV (6 to <72 Months)","deltaMin":24,"sd":null},{"arm":"TIV (6 to <72 Months)","deltaMin":27,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG002","p":null},{"comp":"OG000 vs OG002","p":null},{"comp":"OG000 vs OG002","p":null}]},"eligibility":{"minAge":"6 Months","sex":"ALL","healthyVolunteers":true,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":34,"countries":["Argentina","Australia","Chile","Philippines","South Africa"]},"refs":{"pmids":["25223266"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":115,"n":3123},"commonTop":["Pyrexia","Injection site pain","Upper respiratory tract infection","Diarrhea","Decreased appetite"]}}